Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity (Q38233071)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

1 reference

based on heuristic

inferred from title

0 references

author name string

Dustin L Cooper

1

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Christopher M Conder

2

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Sam Harirforoosh

3

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

language of work or name

0 references

publication date

23 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Expert Opinion on Drug Delivery

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

1661-1680

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Nanomaterials and nanoparticles: sources and toxicity

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Drug delivery and nanoparticles:applications and hazards

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Current trends in the application of nanoparticles in drug delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Challenges in development of nanoparticle-based therapeutics

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Biodegradable polymeric nanoparticles based drug delivery systems

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Gastrointestinal uptake of biodegradable microparticles: effect of particle size

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Endocytosis of nanomedicines.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Preparation and characterization of cationic PLGA nanospheres as DNA carriers.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

The shape of things to come: importance of design in nanotechnology for drug delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Shape effects of filaments versus spherical particles in flow and drug delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Particle diameter influences adhesion under flow

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transport

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Polymer nanoparticles

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Nanoparticle characterization: state of the art, challenges, and emerging technologies.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Design and optimization of PLGA-based diclofenac loaded nanoparticles

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Preparation and characterization of liposomes as therapeutic delivery systems: a review

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Liposome: classification, preparation, and applications

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Pharmaceutical nanotechnology for oral delivery of anticancer drugs

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Solid lipid nanoparticles: production, characterization and applications

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Absorption, disposition and pharmacokinetics of solid lipid nanoparticles

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

PLGA-based nanoparticles: an overview of biomedical applications.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Current advances in research and clinical applications of PLGA-based nanotechnology

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Nanovehicular intracellular delivery systems

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

In vivo release kinetics of octreotide acetate from experimental polymeric microsphere formulations using oil/water and oil/oil processes

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Drug delivery systems: An updated review

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Role of monensin PLGA polymer nanoparticles and liposomes as potentiator of ricin A immunotoxins in vitro

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Partially polymerized liposomes: stable against leakage yet capable of instantaneous release for remote controlled drug delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Dendrimers and dendritic polymers in drug delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Nanoparticle-based targeted drug delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Carboxymethyl chitosan-poly(amidoamine) dendrimer core-shell nanoparticles for intracellular lysozyme delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Polymeric micelles for delivery of poorly water-soluble compounds

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Conjugated polymer nanoparticles: preparation, properties, functionalization and biological applications

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Conjugated polymer nanoparticles for drug delivery and imaging

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Synergistic action of doxorubicin bound to the polymeric carrier based on N-(2-hydroxypropyl)methacrylamide copolymers through an amide or hydrazone bond

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Targeted hyperthermia using metal nanoparticles

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Shape-Controlled Synthesis of Colloidal Platinum Nanoparticles

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Effects of a potent antioxidant, platinum nanoparticle, on the lifespan of Caenorhabditis elegans

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Introduction to metallic nanoparticles

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Hydroxycamptothecin-loaded Fe3O4 nanoparticles induce human lung cancer cell apoptosis through caspase-8 pathway activation and disrupt tight junctions

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Carbon nanotubes hybrid hydrogels in drug delivery: a perspective review

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

The cancer targeting potential of D-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Quantum dots for live cells, in vivo imaging, and diagnostics

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Subcellular targeting strategies for drug design and delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Albumin-bound paclitaxel: a next-generation taxane

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

New method for analysis of biodegradable polyesters by high-performance liquid chromatography after alkali hydrolysis

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Biodegradation and biocompatibility of PLA and PLGA microspheres

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Polymeric nanoparticles for increased oral bioavailability and rapid absorption using celecoxib as a model of a low-solubility, high-permeability drug

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Amphotericin B-induced nephrotoxicity: a review

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Risk factors for amphotericin B-induced nephrotoxicity

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Attenuation of nephrotoxicity by a novel lipid nanosphere (NS-718) incorporating amphotericin B.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Clinical pharmacokinetics of vancomycin

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Protective effect of inactive ingredients against nephrotoxicity of vancomycin hydrochloride in rats

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Decreased renal accumulation and toxicity of a new VCM formulation in rats with chronic renal failure

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Established and newly proposed mechanisms of chronic cyclosporine nephropathy

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

The role of tacrolimus in inflammatory bowel disease: a systematic review

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Cisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Genistein protects the kidney from cisplatin-induced injury.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

The reversal of cisplatin-induced nephrotoxicity by selenium nanoparticles functionalized with 11-mercapto-1-undecanol by inhibition of ROS-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Comparative study of the ocular efficacy and safety of diclofenac sodium (0.1%) ophthalmic solution with that of ketorolac tromethamine (0.5%) ophthalmic solution in patients with acute seasonal allergic conjunctivitis

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Development of solid nanoparticles based on hydroxypropyl-β-cyclodextrin aimed for the colonic transmucosal delivery of diclofenac sodium

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

A phase 2 study evaluating the efficacy and safety of a novel, proprietary, nano-formulated, lower dose oral diclofenac

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

New heparin-indomethacin conjugate with an ester linkage: synthesis, self aggregation and drug delivery behavior

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Coxibs and cardiovascular side-effects: from light to shadow.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Selective cyclooxygenase-2 inhibitors: similarities and differences

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Silica-lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: An in vivo evaluation.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Calcium-based nanoparticles accelerate skin wound healing

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Can the pharmaceutical industry reduce attrition rates?

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Triblock copolymers: synthesis, characterization, and delivery of a model protein

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Methods to assess in vitro drug release from injectable polymeric particulate systems

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Biodegradable microparticles for sustained release of a new GnRH antagonist--part I: Screening commercial PLGA and formulation technologies.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Leuprolide acetate: pharmaceutical use and delivery potentials.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Population pharmacokinetics of liposomal daunorubicin in children

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Time-dependent pharmacokinetics of cyclosporine (Neoral) in de novo renal transplant patients

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Review of comparative studies between conventional and liposomal amphotericin B (Ambisome) in neutropenic patients with fever of unknown origin and patients with systemic mycosis

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Nanoparticles in medicine: therapeutic applications and developments

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Oral Delivery of Doxorubicin Using Novel Polyelectrolyte-Stabilized Liposomes (Layersomes)

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.938046

21 January 2018

Identifiers

10.1517/17425247.2014.938046

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38233071&oldid=1748758829"